SCHEMBL2596485

SCHEMBL2596485

CN[C@H]1CC[C@H](OC(=O)[C@](O)(c2ccccc2)C2CCCC2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 8/20 0.63
CHRM2 P08172 3/20 0.63
ALDH1A1 P00352 2/20 0.62
CHRM1 P11229 2/20 0.62
KCNH2 Q12809 2/20 0.62
CYP1A2 P05177 2/20 0.62
CHRM4 P08173 1/20 0.62
CHRM5 P08912 1/20 0.62
HRH1 P35367 1/20 0.62
HTR2B P41595 1/20 0.62
CYP3A4 P08684 2/20 0.61
CYP2D6 P10635 2/20 0.61
KEAP1 Q14145 1/20 0.54
NFE2L2 Q16236 1/20 0.54
POLB P06746 1/20 0.50
SLC6A3 Q01959 1/20 0.48
CYP2C9 P11712 1/20 0.47
PKM P14618 1/20 0.47
NFKB1 P19838 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14753777 0.85 CYP3A4 (0.70) CHRM3CHRM2ALDH1A1CHRM1KCNH2
SCHEMBL14753782 0.85 CYP3A4 (0.70) CHRM3CHRM2ALDH1A1CHRM1KCNH2
SCHEMBL2596419 0.81 CHRM3 (0.56) CHRM3CHRM2ALDH1A1CHRM1KCNH2
SCHEMBL1222146 0.81 CHRM3 (0.88) CHRM3CHRM2ALDH1A1CHRM1KCNH2
SCHEMBL4298699 0.81 ALDH1A1 (0.86) CHRM3CHRM2ALDH1A1CHRM1KCNH2
SCHEMBL1234889 0.81 KEAP1 (0.70) CHRM3CHRM2ALDH1A1CHRM1KCNH2
SCHEMBL2062807 0.81 KEAP1 (0.70) CHRM3CHRM2ALDH1A1CHRM1KCNH2
SCHEMBL522945 0.81 KEAP1 (0.70) CHRM3CHRM2ALDH1A1CHRM1KCNH2
SCHEMBL20476344 0.81 CHRM3 (0.64) CHRM3CHRM2ALDH1A1CHRM1KCNH2
Bromide SCHEMBL3387205 0.80 CHRM3 (0.88) CHRM3CHRM2ALDH1A1CHRM1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011141180-A1 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES ALMIRALL, S.A. (ES) 2011-11-17 WO disclosed